First patient enrolled in stem cell therapy trial for traumatic injury
The first patient has enrolled in a Phase II clinical trial evaluating a stem cell therapy for the potential early treatment of traumatic injuries and their subsequent complications at The University of Texas Health Science Center at Houston (UTHealth). The…
Cox, research team: Stem cell therapy appears to have TBI treatment effect
Results of a cellular therapy clinical trial for traumatic brain injury (TBI) using a patient’s own stem cells showed that the therapy appears to dampen the body’s neuroinflammatory response to trauma and preserve brain tissue, according to researchers at UTHealth….
The Q&A Charles Cox
Dr. Charles Cox is a pediatric neurosurgeon at the McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth). He is also the co-director of the Red Duke Memorial Hermann Trauma Institute. He and his research team were…
UTHealth receives $6.8 million from DOD to study stem cell therapy for TBI
HOUSTON – (2016) – A research team led by Charles S. Cox, Jr., M.D., at The University of Texas Health Science Center at Houston (UTHealth) has been awarded $6.8 million from the U.S. Department of Defense (DOD) to assess the…